CCM® Therapy

Impulse Dynamics is determined to improve the lives of people with heart failure and is the developer of the innovative Optimizer® CCM® Therapy delivery system. CCM Therapy is a breakthrough heart failure treatment proven to improve quality of life for heart failure patients. CCM Therapy is specifically designed to improve systolic contraction in an effort to deliver more oxygen-rich blood to the body. CCM Therapy is a safe and effective, minimally invasive treatment option for millions of heart failure patients who otherwise have few or no effective options available to them. Optimizer® is the first and only FDA-approved device in the U.S. or elsewhere for the delivery of CCM Therapy.

Our mission at Impulse Dynamics is to exceed the expectations of patients, clinicians, and caregivers alike by developing and providing cardiac contractility modulation. The company believes in fostering innovation, transparency, and accountability in our relentless efforts to expand global access to the benefits of CCM Therapy.

www.impulsedynamics.com


 

THT 2024: CCM® Therapy in Addition to GDMT: Optimizing Strategy for Heart Failure

107 views
March 20, 2024
This session from THT 2024 will explain what Cardiac Contractility Modulation therapy is, how it works, and the expected outcomes when utilizing this treatment for HF in NYHA Class III patients who remain symptomatic despite guideline-directed medical therapy. Dr. Javed Butler discusses the challenges that continue to exist in the treatment of heart failure and the unmet needs the provider community must face together. (0:00 – 9:45) Dr. Niraj Varma introduces the Integra D Trial design and inclusion criteria. CCM-D is an investigational device in clinical trials that has both CCM and defibrillator capabilities. (9:46 – 22:07) Dr. Rami Kahwash talks about his experiences with CCM® therapy and approaches to identify appropriate candidates in patients with limited options available to improve their symptoms and quality of life. He presents his personal experience with a case study. (22:08 – 37:40) Finally, the panel addresses questions and provides answers. (37:41 – 54:47)

THT 2024: Heart Failure Management Today – GDMT, CRT, and CCM® Therapy

THT 2024: Update on the Integra-D Trial - CCM® Therapy

THT 2024: CCM® Therapy - Don’t Wait!
Comments 0
Login to view comments. Click here to Login